Related content

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

By Máiz Luis   Girón Rosa M   Olveira Casilda   Quintana Esther   Lamas Adelaida   Pastor Dolores   Cantón Rafael   Mensa Josep  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1135-1149

Informa Healthcare

Access to resources Recommend Favorite

Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies

By Hassett Daniel J   Korfhagen Thomas R   Irvin Randall T   Schurr Michael J   Sauer Karin   Lau Gee W   Sutton Mark D   Yu Hongwei   Hoiby Niels  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite

Transmission of Pseudomonas aeruginosa from Nail to Wound Infection

By VERGILIS IRENE   GOLDBERG LEONARD H.   LANDAU JENNIFER   MALTZ ASHLEY  

Dermatologic Surgery, Vol. 37, Iss. 1, 2011-01 ,pp. : 105-106

Elsevier

Access to resources Recommend Favorite

Inhalable Antibiotic Nanoformulations for the Treatment of Pseudomonas Aeruginosa Infection in Cystic Fibrosis – A Review

By  

Drug Delivery Letters, Vol. 4, Iss. 3, 2014-12 ,pp. : 193-207

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into antifolate activity of phytochemicals against Pseudomonas aeruginosa

By Jayaraman Premkumar   Sakharkar Kishore R.   Sing Lim Chu   Chow Vincent T.K.   Sakharkar Meena K.  

Journal of Drug Targeting, Vol. 19, Iss. 3, 2011-04 ,pp. : 179-188

Informa Healthcare

Access to resources Recommend Favorite